Summary
- OCID:
- ocds-kuma6s-127596
- Published by:
- Swansea University
- Authority ID:
- AA0345
- Publication date:
- 04 April 2023
- Deadline date:
- -
- Notice type:
- Contract Award Notice
- Has documents:
- No
- Has SPD:
- No
- Has Carbon Reduction Plan:
- No
Abstract
The Reproductive Biology and Gynaecological Oncology (RBGO) group within the Faculty of Medicine, Health & Life Science at Swansea University have procured a Live Cell Analysis system to expand the capabilities of the group. Procurement of this instrument will support academic and industrial collaborations developed as part of two ERDF funded, SMARTExpertise projects; the Cluster for Epigenetic and ADC Therapeutics (CEAT) and ReNeuron, IgInnovations and Swansea University's development of Exosomes towards clinical utility (RISE).
A condition of the funding body covering this equipment is that it must be invoiced (not necessarily delivered) on receipt of a Swansea University Purchase Order, prior to 31st March 2023.
The RBGO Group have conducted an open tender process to source a suitable supplier of a live cell analysis system. The system will allow the group to monitor live 2D and 3D cell cultures in an optimal environment for growth. The system will allow the user to obtain data such as confluency, spheroid growth rate, cell migration, apoptosis, cell cycle stage and cytotoxicity.
Full notice text
CONTRACT AWARD NOTICE – NATIONAL
|
| SUPPLIES |
1 Authority Details
|
1.1
|
Authority Name and Address
|
|
Swansea University |
Procurement Office, Swansea University, Singleton Park, |
Swansea |
SA2 8PP |
UK |
Sue Davies |
+44 1792295890 |
|
|
| https://www.swansea.ac.uk |
|
2 Contract Details
|
2.1
|
Title
Contract for a Live-Cell Analysis System
|
2.2
|
Description of the contract
The Reproductive Biology and Gynaecological Oncology (RBGO) group within the Faculty of Medicine, Health & Life Science at Swansea University have procured a Live Cell Analysis system to expand the capabilities of the group. Procurement of this instrument will support academic and industrial collaborations developed as part of two ERDF funded, SMARTExpertise projects; the Cluster for Epigenetic and ADC Therapeutics (CEAT) and ReNeuron, IgInnovations and Swansea University's development of Exosomes towards clinical utility (RISE).
A condition of the funding body covering this equipment is that it must be invoiced (not necessarily delivered) on receipt of a Swansea University Purchase Order, prior to 31st March 2023.
The RBGO Group have conducted an open tender process to source a suitable supplier of a live cell analysis system. The system will allow the group to monitor live 2D and 3D cell cultures in an optimal environment for growth. The system will allow the user to obtain data such as confluency, spheroid growth rate, cell migration, apoptosis, cell cycle stage and cytotoxicity.
|
2.3
|
Notice Coding and Classification
|
|
|
|
|
33000000 |
|
Medical equipments, pharmaceuticals and personal care products |
|
33100000 |
|
Medical equipments |
|
33110000 |
|
Imaging equipment for medical, dental and veterinary use |
|
33190000 |
|
Miscellaneous medical devices and products |
|
33197000 |
|
Medical computer equipment |
|
33698100 |
|
Microbiological cultures |
|
38430000 |
|
Detection and analysis apparatus |
|
38432000 |
|
Analysis apparatus |
|
38434540 |
|
Biomedical equipment |
|
|
|
|
|
1018 |
|
Swansea |
|
2.4
|
Estimated Total Value |
3 Procedure
|
3.1
|
Type of ProcedureSingle stage |
4 Award of Contract
|
4.1
|
Successful Bidders
|
4.1.1
|
Name and Address of successful supplier, contractor or service provider
SU108(23)
PerkinElmer LAS (UK) Ltd |
Chalfont Road, Seer Green, |
Beaconsfield |
HP9 2FX |
UK |
|
|
|
|
|
|
5 Other Information
|
5.1
|
Reference number attributed to the notice by the contracting authority
SU108(23)
|
5.2
|
Date of Contract Award 16-03-2023 |
5.3
|
Number of tenders received
2
|
5.4
|
Other Information
(WA Ref:130567)
Relates to the following project/programme financed by EU Community Funds: Procurement of this instrument will support academic and industrial collaborations developed as part of two ERDF funded, SMARTExpertise projects; the Cluster for Epigenetic and ADC Therapeutics (CEAT) and ReNeuron, IgInnovations and Swansea University's development of Exosomes towards clinical utility (RISE).
|
5.5
|
Additional DocumentationN/a |
5.6
|
Publication date of this notice: 04-04-2023 |
Coding
Commodity categories
| ID |
Title
|
Parent category
|
| 38432000 |
Analysis apparatus |
Detection and analysis apparatus |
| 38434540 |
Biomedical equipment |
Analysers |
| 38430000 |
Detection and analysis apparatus |
Instruments for checking physical characteristics |
| 33110000 |
Imaging equipment for medical, dental and veterinary use |
Medical equipments |
| 33197000 |
Medical computer equipment |
Miscellaneous medical devices and products |
| 33100000 |
Medical equipments |
Medical equipments, pharmaceuticals and personal care products |
| 33000000 |
Medical equipments, pharmaceuticals and personal care products |
Materials and Products |
| 33698100 |
Microbiological cultures |
Clinical products |
| 33190000 |
Miscellaneous medical devices and products |
Medical equipments |
Delivery locations
| ID |
Description
|
| 1018 |
Swansea |
Alert region restrictions
The buyer has restricted the alert for this notice to suppliers based in the following regions.
| ID |
Description
|
|
There are no alert restrictions for this notice.
|
Document family
|
Notice details
|
- Publication date:
- 20 December 2022
- Deadline date:
- 20 January 2023 00:00
- Notice type:
- Contract Notice
- Authority name:
- Swansea University
|
- Publication date:
- 04 April 2023
- Notice type:
- Contract Award Notice
- Authority name:
- Swansea University
|
About the buyer
- Main contact:
- N/a
- Admin contact:
- N/a
- Technical contact:
- N/a
- Other contact:
- N/a
Further information
|
Date
|
Details
|
|
No further information has been uploaded.
|